99 related articles for article (PubMed ID: 12882711)
1. [The combination of octreotide to rofecoxib enhanced the inhibitory effect on growth of human hepatocellular carcinoma].
Liu CL; Tang CW; Zhou XC
Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):313-5. PubMed ID: 12882711
[TBL] [Abstract][Full Text] [Related]
2. [Effects of combination of octreotide and aspirin on proliferation of human hepatocellular carcinoma].
Tang CW; Tang LP; Wang CH
Ai Zheng; 2002 Apr; 21(4):383-7. PubMed ID: 12452016
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
Wang C; Tang C; Tang L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
[TBL] [Abstract][Full Text] [Related]
4. Enhanced inhibitive effects of combination of rofecoxib and octreotide on the growth of human gastric cancer.
Tang C; Liu C; Zhou X; Wang C
Int J Cancer; 2004 Nov; 112(3):470-4. PubMed ID: 15382074
[TBL] [Abstract][Full Text] [Related]
5. [The effects of selective cyclooxygenase-2 inhibitors on the growth of gastric adenocarcinoma].
Liu C; Tang C; Wan X; Wang C; Zhou X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):480-3. PubMed ID: 12910695
[TBL] [Abstract][Full Text] [Related]
6. Effect of octreotide on angiogenesis induced by hepatocellular carcinoma in vivo.
Jia WD; Xu GL; Sun HC; Wang L; Xu RN; Xue Q
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):404-9. PubMed ID: 14599948
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
Wang CH; Tang CW
Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
Ghous Z; Akhter J; Pourgholami MH; Morris DL
Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay].
Shi LX; Lu R; Wang L; Zhou CL; Xu Q; Zhu ZF; Ma R; Zhang HL; Jia J; Fu Z; Yao Z
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):725-8. PubMed ID: 19173797
[TBL] [Abstract][Full Text] [Related]
10. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
Liu HL; Huo L; Wang L
Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
Gong ZB; Liu JM; Li YM
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531
[TBL] [Abstract][Full Text] [Related]
12. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
13. [Effect of HBV X gene transfection on octreotide-inhibited growth of hepatocellular carcinoma cell line HepG2].
Xie Y; Tang CW; Wang CH
Ai Zheng; 2005 Aug; 24(8):965-9. PubMed ID: 16086874
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model.
Lin RX; Tuo CW; Lü QJ; Zhang W; Wang SQ
Acta Pharmacol Sin; 2005 Jun; 26(6):762-8. PubMed ID: 15916744
[TBL] [Abstract][Full Text] [Related]
15. [Effects of octreotide on necrosis of hepatocellular carcinoma xenografts in nude mice].
Chen S; Xie Y; Wang CH; Tang CW
Ai Zheng; 2009 Jul; 28(7):673-8. PubMed ID: 19624890
[TBL] [Abstract][Full Text] [Related]
16. Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancer.
Treiber G; Röcken C; Wex T; Malfertheiner P
Z Gastroenterol; 2007 May; 45(5):369-77. PubMed ID: 17503315
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
[TBL] [Abstract][Full Text] [Related]
18. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]